Varex Imaging reported higher revenue, stronger non-GAAP margins and improved earnings, although tariff refunds and related customer reimbursements provided a roughly $10 million benefit to quarterly gross profit.
Key Investor Takeaways
- Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue of $211 million, up 4% year over year, with Industrial revenue reaching $77 million and Medical revenue at $134 million.
- Non-GAAP gross margin expanded to 37% from 34%, while non-GAAP EPS increased to $0.31 from $0.13 a year earlier.
- IEEPA tariff refunds and expected customer reimbursements increased quarterly gross profit by approximately $10 million, making the underlying margin picture important for investors to assess.
- Operating cash flow reached $21 million, although cash, cash equivalents and marketable securities declined to $99 million from $155 million at fiscal 2025 year-end.
- The pending transaction with Teledyne Technologies is now a central consideration for VREX investors, with Varex cancelling its earnings call and declining to issue financial guidance.
Why VREX Stock Is in Focus
Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue growth alongside substantial improvement in margins and earnings, supported by continued strength in its Industrial business.
Revenue increased 4% year over year to $211 million. Before a $7 million adjustment for expected customer reimbursements related to previously billed IEEPA tariffs, management said product sales were approximately $217 million.
Industrial revenue was $77 million, with Varex citing strong growth and continued expansion in cargo and vehicle inspection systems. Medical revenue accounted for $134 million.
Non-GAAP gross margin rose to 37% from 34% in the prior-year quarter, while non-GAAP operating margin reached 12%. Non-GAAP diluted EPS more than doubled to $0.31 from $0.13.
Investors should note the tariff-related impact on profitability. Varex received $17 million in refunds from U.S. Customs for previously paid IEEPA tariffs and recorded the $7 million revenue reduction for expected customer reimbursements. Combined, those items increased Q3 gross profit by approximately $10 million.
Why This Matters for Investors
The results indicate improving operating performance, particularly through Industrial sales and stronger reported margins. The increase in non-GAAP EPS also shows substantially higher quarterly earnings compared with the prior year.
However, the tariff recovery means part of the gross profit improvement came from a specific reimbursement event rather than solely from underlying operations. That could make future margin performance without the approximately $10 million benefit an important indicator of the company’s operating trajectory.
Cash generation was positive, with $21 million of operating cash flow during the quarter. At the same time, cash, cash equivalents and marketable securities declined to $99 million from $155 million at the end of fiscal 2025.
Varex attributed the decline primarily to its March debt redemption and refinancing and increased working capital associated with inventory.
The investment narrative is also being reshaped by the announced transaction with Teledyne Technologies. Varex cancelled its scheduled Q3 earnings conference call and will not provide financial guidance while the transaction is pending.
What to Watch Next
Investors may focus on developments surrounding the Teledyne transaction and any information provided about its progression.
For the underlying business, Industrial growth, cargo and vehicle inspection demand, operating cash generation and margins excluding the Q3 tariff-related benefit could provide useful indications of operating momentum.